New Delhi, Jan 16: Seeking to provide relief to heart patients, The National Pharmaceutical Pricing Authority (NPPA) has proposed to slash the prices of life-saving coronary stents by 50 percent. If the move is accepted, patients will not have to shell out whopping Rs 70,000 for these bio-degradable stents.
If the proposal is accepted, it will become effective from February. The stents have been primarily placed under two categories - drug-eluting stents (DES) and bare-metal stents (BMS) with NPPA setting out an option to fix prices.
The NPPA's proposals have added fuel to an ongoing debate about which formula for capping these devices would improve patient access, without making the stent industry unviable.
Meanwhile, the pricing decision is now in its final stages with NPPA asking all stakeholders to submit suggestions on the proposed options by January 26.
The regulator has also asked companies to submit documents and relevant data to support their representations.